Filter
1054
Filtered Results: 1054
Text search:
viral
suppression
Featured
Recommendations
94
New Publications
277
Language
Document type
No document type
666
Guidelines
151
Studies & Reports
141
Manuals
28
Strategic & Response Plan
20
Fact sheets
17
Infographics
16
Training Material
7
Situation Updates
6
Brochures
2
Countries / Regions
India
54
Kenya
36
South Africa
34
Global
33
Africa
27
Malawi
23
Zambia
21
Ethiopia
19
Nepal
18
Tanzania
17
Myanmar / Burma
16
Nigeria
15
Uganda
15
Lesotho
12
Asia
12
Rwanda
10
Congo, Democratic Republic of
10
Ghana
9
Zimbabwe
9
Philippines
9
South–East Asia Region
9
East and Southern Africa
9
Bangladesh
9
Namibia
9
Sierra Leone
8
Senegal
8
Liberia
8
Latin America and the Carribbean
7
Western and Central Europe
7
Cambodia
6
Venezuela
6
West and Central Africa
6
Brazil
6
Ukraine
5
Burkina Faso
5
Eswatini/ Swaziland
5
Syria
4
Mozambique
4
Germany
4
Georgia
4
Cameroon
3
Albania
3
Haiti
3
Eastern Europe and Central Asia
3
Paraguay
3
Eastern Europe
3
Russia
3
Yemen
3
Botswana
3
Indonesia
3
Colombia
2
Thailand
2
Benin
2
Burundi
2
Guinea
2
Armenia
2
USA
2
Middle East and North Africa
2
France
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Vietnam
2
Mali
2
Iraq
2
Madagascar
2
North Macedonia
1
North Korea
1
Timor Leste/ East Timor
1
Serbia
1
Togo
1
Chile
1
Canada
1
Estonia
1
Congo-Brazzaville
1
Niger
1
Western Pacific Region
1
Luxembourg
1
Belgium
1
Southern Africa
1
Sri Lanka
1
Djibouti
1
Angola
1
Chad
1
Bhutan
1
South Sudan
1
Somalia
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
180
Guidelines
61
Studies & Reports
61
Statistics
48
HIV & STI
47
COVID-19
33
Capacity Building
25
Policies
24
Women & Child Health
23
Drugs & Medical Equipment
16
Hepatitis
12
Non-communicable Diseases
12
Pediatrics
10
Community Health
10
Humanitarian Crisis
10
Health Systems
8
TB
7
Paediatrics
6
Disaster Preparedness
6
Vaccine-preventable Diseases
6
Communicable Diseases
5
Countries
4
Information, Education and Communication (IEC)
4
Maternal Health
4
Disease Prevention & Control
4
Family Planning
3
Dermatology
3
Humanitarian Aid
3
Community Health
3
Communicable Diseases
3
Gynaecology & Obstetrics
3
NTDs & Others
3
Age & Elderly
3
Key Resources
3
Reproductive Health
3
Under-5 nutrition
2
Vector Control
2
Palliative Care
2
Virology
2
Infection Control & Prevention (IPC)
2
Yersinia pestis (Plague)
2
Hemorrhagic Fever
2
Clinical Guidelines
2
Demograhic Health Surveys DHS
2
Palliative Care
2
Other
2
Quality Control & Assurance
2
Needs Assessment
2
Protection & Security
2
Women & Child Health
2
Dengue
2
Malaria
2
Dental & Eye Care
1
Rabies
1
Public Health
1
Child Health
1
Diabetes
1
Bacteriology
1
Hematology
1
Gender
1
Schistosomiasis
1
Laboratory Waste
1
Annual Report MEDBOX
1
x MEDBOX Issue Brief & Annual Reports x
1
Monitoring & Evaluation
1
Cervical Cancer
1
Cancer Treatment & Resources
1
MPOX - Monkeypox
1
Maternal & Child Health
1
Sexual Violence
1
Health System Strengthening
1
Violence against Children
1
Training Manuals
1
Yellow Fever
1
Disabilities
1
Leprosy
1
Waste Management
1
COPD/Asthma
1
Leprosy
1
Primary Health Care
1
Leishmaniasis
1
Human African Trypanosomiasis
1
Neonatal Care
1
Global Health
1
Pharmacy & Technologies
1
Radiology and Diagnostic
1
Toolboxes
Reports & Studies
69
Children & Adolescents
53
Eastern Europe and central Asia
38
Clinical Aspects, Treatment & Prevention
31
Treatment & Prevention
31
General Reports
25
Global
25
Policies
23
Antiretroviral Treatment ART
23
Country specific documents
21
HIV testing & services
20
Universal Health Coverage UHC and 90-90-90 Strategy
20
ART Drug Resistance
19
Reports & Studies Children HIV
18
Treatment Guidelines HIV
17
Clinical Aspects
14
HIV in Key Populations
14
Asia and Pacific
13
Prevention of mother-to-child transmission (PMTCT)
13
HIV service delivery
12
Epidemiology
12
Eastern and Southern Africa
12
Global Impact: Socio-economic, health services, TB & HIV
11
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
11
HIV
10
Clinical Guidelines
10
Co-Morbidities (except TB)
10
Laboratory
9
Regions
9
TB/HIV Coinfection
9
Public Health
8
Drug resistance
8
Access to treatment and laboratory
8
Testing Guidelines
8
Lobby and Advocacy
8
Opportunistic Infections
7
Prevention Guidelines
7
Adherence
7
Diagnostics & Laboratory Guidance
7
Latin America & the Carribean
7
Prevention & Preparedness
6
HIV and COVID-19
6
Policies and guidelines
6
HIV and coinfection
6
Epidemiology
6
HIV in Children and mental health
5
Substance Use Disorders, Others
5
HIV testing & disclosure
5
People who injecting Drugs
5
Children/Adolescents Mental Disorders
5
Inactivated COVID-19 Vaccines
5
Women
5
Substance Use Disorders & Addiction
5
General Aspects
5
TB & Drug Abuse
4
Key Resources
4
HIV surveillance
4
South Africa
4
Men who have sex with men (MSM)
4
Others
4
Discrimination & Stigma
4
General
4
Appeals and Response Plans
4
Rational use of Medicine
4
Health Financing Toolbox
4
Prevention & Strategies
4
Community Worker
4
Male Circumcision
3
Hepatitis
3
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
3
Context & Facts, Travel Advice
3
Infection Control General
3
Simulations
3
Immunization Guidelines
3
TB/HIV
3
Pharmacy Practice
3
Neurological Disorders
3
Disease Prevention & Control
3
Prophylactic Treatment
3
IEC Material Children HIV
3
Psychosocial Support (MHPSS)
2
Assessment & Studies
2
Childhood TB
2
Children with Disabilities
2
Surveillance
2
Country specific
2
Vector Control
2
Prevention & Control
2
Influenza Prevention & Control
2
Adults
2
Children
2
Country Guidelines
2
Epilepsy
2
HIV / AIDS
2
Sustainable Development Goals
2
International
2
Treatment Guidelines
2
Health Personnel
2
Training, others
2
Clinical Guidelines
2
Country Specific
2
Prison & Detention
2
Protection of Vulnerable Groups
2
COVID-19
2
RCCE Guides & Manuals
2
Psychosocial Support
2
Standard Operating Procedure (SOP)
2
Studies & Reports
2
Community Health Workers CHW
2
Nurses
2
Essential Medicines & Devices Lists
2
Model Formulary
2
Women & Maternal Health
2
Agriculture incl. animal husbandry
2
General Guidelines for Rational Use
2
Waste Managment
2
Ethics
2
MPOX - Monkeypox
2
MPOX -Monkeybox Prevention & Control
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Overview, Studies & Reports
2
Health Worker
2
Prevention & Strategies
2
Others
2
Clinical Aspects & Diagnosis
2
Malawi
2
Disaster Preparedness & Prevention
2
Dengue Prevention & Control
2
Uganda
2
Assessment
2
Others
2
South-east Asia Region
2
TB
2
Kenya
2
Prisoners
2
Meningitis & Encephalitis
2
Capacity Building
2
Plague Prevention & Control
2
War & Conflict
1
Disability Rights & Convention
1
Drugs
1
Alcohol
1
Violence & Child Trafficking
1
Cholera Situation Reports
1
Sexual and gender-based violence (SGBV)
1
Behaviour Change/Life Skill Education
1
Policies & Strategies
1
HIV support organizations
1
Clinical Guidelines
1
Advocacy
1
Posttraumatic stress disorder Adults
1
Training
1
Chemical Attacks
1
For General Public
1
Yellow Fever
1
Vaccination
1
Ukraine
1
WASH
1
Plague
1
South Sudan
1
Assessment & Response
1
Humanitarian Settings
1
Context, Facts & Travel Advice
1
Capacitiy Building
1
Clinical Guidelines
1
Training Manuals
1
Transgender People
1
General Mental Health Guidelines
1
mhGAP Guides
1
Eastern Europe
1
Africa
1
General Studies & Reports
1
Mental Health
1
Rwanda
1
Physiotherapy & Rehabilitation
1
Syria
1
Human Rights
1
Training Supporting Material mhGAP
1
Clinical aspects
1
Women's Mental Health
1
Reports
1
IEC Substance Use Disorders
1
Clinical Guidelines
1
Research & Development
1
Studies
1
General
1
Infection Prevention & Hygiene
1
Clinical Aspects
1
Covid-19 & the One Health Approach
1
Covid-19 & Climate Change
1
COVID-19
1
For General Public & Community
1
For Pregnant Women
1
For Health Worker
1
For Migrants & Refugees
1
Scientific & Research Studies
1
Resource Platforms others
1
Food and Nutrition
1
Gender Aspects
1
Sustainability
1
Educational Settings
1
Physical Distancing
1
General
1
MHPSS – Psychosocial Support
1
Coping with Stress
1
Essential Medicines & Medical Devices
1
Blood Supply
1
Access & Strategy
1
Non-pharmaceutical interventions (NPIs)
1
Preparedness, Response & Risk Communication
1
TB/COVID-19
1
Long COVID/ Post-COVID Syndrome
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Covaxin
1
Waste Management
1
Others
1
Others
1
Extreme Situations
1
Midwives
1
Chile
1
Medical Records/Documentation
1
Climate Change General
1
Reports
1
Food environments
1
Agriculture
1
Overview & reports
1
Essential Medicines
1
Resuscitation
1
HIV &TB
1
Pediatrics
1
General documents One Health
1
Epilepsy
1
Climate Change
1
Guidelines & Manuals
1
Environment
1
Information Refugees Ukraine
1
Prevention & Measures
1
Zoonoses
1
General
1
General
1
More Clinical Guidelines on Palliative Care
1
MPOX - Monkeypox
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Information & Education Material (IEC)
1
Vector control
1
West and central Africa
1
General Information
1
Prevention & Strategies
1
Studies & Reports
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Studies & Reports
1
Global Overview
1
Detection & Diagnosis
1
Diagnosis
1
Drug resistant TB
1
others
1
Technical Information
1
Ghana
1
Policies & Strategies
1
Assistive devices & technologies
1
Assessment & Response
1
TB & Prisoners
1
For Community Health Workers
1
Tuberculosis
1
Nutrition
1
Assessment & Response
1
Research & Access
1
Germany
1
Lesotho
1
Stewardship
1
Chikungunya Prevention & Control
1
Zika Prevention & Control
1
Clinical Guidelines
1
Western & Central Europe
1
WASH
1
Guidelines CBR
1
Psychosocial Support
1
Paediatrics
1
Laboratory & Diagnostics
1
Depression
1
Mental Health GAP Action Programme
1
Global Health Ethics
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people who use drugs, the distribution of those users by type of drug...
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
The Country Cooperation Strategy (CCS) is a document to guide WHO’s work in countries. CCS is a medium-term vision for WHO’s technical cooperation with a given Member State, and supports the country's national health policy, strategy or plan. The CCS time frame is flexible to align with national...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F...
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i...
In Danger: UNAIDS Global AIDS Update 2022
recommended
Progress in prevention and treatment is faltering around the world, putting millions of people in grave danger. Eastern Europe and central Asia, Latin America, and the Middle East and North Africa have all seen increases in annual HIV infections over several years. In Asia and the Pacific, UNAIDS da...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
